Hence, our study suggested PAI-1 may be a valuable target in breast cancer, targeting PAI-1 could inhibit cancer cells migration and abrogated PLOD2-mediated collagen reorganization in tumor microenvironment. Here, SERPINE1 is linked to cancer.